Shares of The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $115.00.
Several equities analysts have recently weighed in on the stock. Morgan Stanley increased their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 10th. Stifel Nicolaus reiterated a “buy” rating and set a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Piper Sandler lifted their target price on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Finally, Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and upped their price target for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th.
View Our Latest Stock Analysis on Cooper Companies
Insiders Place Their Bets
Institutional Investors Weigh In On Cooper Companies
Several large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in shares of Cooper Companies by 303.0% during the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after buying an additional 17,367,502 shares during the period. Capital World Investors increased its position in Cooper Companies by 301.7% during the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock valued at $573,657,000 after purchasing an additional 4,246,519 shares during the period. Janus Henderson Group PLC increased its position in Cooper Companies by 279.8% during the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock valued at $348,723,000 after purchasing an additional 2,532,186 shares during the period. Bessemer Group Inc. raised its holdings in shares of Cooper Companies by 305.2% in the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after purchasing an additional 1,507,049 shares in the last quarter. Finally, Swedbank AB purchased a new stake in shares of Cooper Companies in the 1st quarter worth approximately $139,246,000. 24.39% of the stock is owned by hedge funds and other institutional investors.
Cooper Companies Stock Up 0.5 %
COO opened at $110.34 on Tuesday. The stock has a market capitalization of $21.97 billion, a price-to-earnings ratio of 64.91, a PEG ratio of 2.63 and a beta of 0.98. The firm has a 50 day moving average price of $100.22 and a 200-day moving average price of $95.78. Cooper Companies has a twelve month low of $75.93 and a twelve month high of $112.38. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33.
Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. During the same period in the prior year, the firm earned $0.84 EPS. The company’s revenue was up 7.8% compared to the same quarter last year. Equities research analysts forecast that Cooper Companies will post 3.65 earnings per share for the current year.
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Recommended Stories
- Five stocks we like better than Cooper Companies
- What is Short Interest? How to Use It
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Best Stocks Under $5.00
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.